Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study

BACKGROUND: Recent clinical trials illustrated that gefitinib plus pemetrexed/platinum regimen improves survival in advanced lung adenocarcinoma patients with EGFR mutation, while data on its efficacy and safety in a real clinical setting are limited. Thus, this real-world observational study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui, Wu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763260/
https://www.ncbi.nlm.nih.gov/pubmed/35046665
http://dx.doi.org/10.2147/OTT.S332998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763260/
https://www.ncbi.nlm.nih.gov/pubmed/35046665
http://dx.doi.org/10.2147/OTT.S332998

Ejemplares similares